Long-Term Follow-up of a Randomized Controlled Trial of Allopurinol Dose Escalation to Achieve Target Serum Urate in People With Gout.
George B ColemanNicola DalbethChristopher M A FramptonJanine HaslettJill DrakeIsabel SuAnne M HorneLisa K StampPublished in: The Journal of rheumatology (2022)
Most of the surviving participants in the allopurinol dose escalation study had good real-world persistence with allopurinol, remained at target SU, and had a low number of self-reported flares.